1 year return (CAGR)
16.86%
Rigel Pharmaceuticals Inc Exchange (NASDAQ, USD)
RIGL
44.36
-0.99 (-2.18%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
59.66%
5 year return (CAGR)
1.89%
10 year return (CAGR)
2.70%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
820.75M
Price/Sales
2.97
Ent value
855.35M
Price/Book
1.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
2.55
PEG
-
Forward P/E
8.98
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 45.14 |
| Daily high | 46.26 |
| Daily low | 44.22 |
| Daily Volume | 270K |
| All-time high | 1068.75 |
| 1y analyst estimate | 63.00 |
| Beta | 1.17 |
| EPS (TTM) | 16.45 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RIGL | S&P500 | |
| Current price drop from All-time high | -95.85% | -2.63% |
| Highest price drop | -99.37% | -56.47% |
| Date of highest drop | 9 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -90.96% | -10.68% |
| Avg time to new high | 540 days | 12 days |
| Max time to new high | 6462 days | 1805 days |
News
